PYREXAR Medical is the pioneer and worldwide market leader in the development and manufacture of innovative and highly effective hyperthermia treatment systems with established global distribution.

The BSD-2000 3D/MR employs the next generation of non-invasive thermometry. MR images are translated to map and visualize temperature, allowing for precision placement of the hyperthermic heating zone.

A great benefit of image guided thermal therapy is the ability to validate and electronically steer the heat zone to ensure proper treatment placement and target temperature.

The Sigma Eye/MR applicator's side opening allows for easier patient access. The unit can be removed and stored allowing the MR system to be used for traditional imaging.

There is no interruption during the hyperthermia/imaging process. The patient remains in the MR system during the full course of treatment. A water bolus is used to make connection between the RF signal and the patient. Circulated water can be cooled or heated for patient comfort

Who is Pyrexar Medical?

Pyrexar Medical was formed to take on the fight against cancer. We purchased the Hyperthermia product line from BSD Medical in April 2015. Our plan is to support the existing BSD-500 and BSD-2000 customers, continue to make product improvements, support the growth of Thermal Oncology and spread the word about this amazing cancer therapy.

Clinical Study Reveals Increased Longevity

The Journal of the American Medical Association (JAMA) just published a 10 year patient follow-up to a phase III clinical study on a Soft Tissue Sarcoma Study. In addition to higher CR, the addition of hyperthermia increased the median long-term survival rate from 6.2 to 15.4 years;

Heat Matters

According to the standards set by the Society of Thermal Medicine (STM); European Society for Hyperthermic Oncology (ESHO) and the Asian Society of Hyperthermic Oncology (ASHO); the benefits of hyperthermia are fully realized when the tumor temperature reaches 39-43 degrees Celsius. Heat is known to kill cancer cells, shrink tumor size, increase radiosensitivity, inhibit DNA repair, oxygenate hypoxic tumors, produce heat shock proteins and increase disease free survival.;

Benefits of Hyperthermia in Cancer Treatment

Shrinks Tumors

In the delicate micro-environment of a cancer cell, heat can lead to direct cell death, shrinking tumors size for easier surgical resection.

Low Toxicity

Very low to no toxicity is often reported when administering hyperthermia. There is no known toxicity build-up from multiple treatments.

Survival Benefit

A phase III clinical study shows an increased survival benefit when hyperthermia was added to chemotherapy.

Increase Blood Flow

Increased blood flow and perfusion at the tumor site promotes oxygenation, increasing radiosensitivity.

Inhibits DNA Repai

Hyperthermia in combination with Radiotherapy will inhibit the DNA repair cycle of radiation damaged cancer cells.

Heat Shock Proteins

Tumor cells express heat shock proteins when exposed to hyperthermic temperatures allowing tumor specific antigens to reach the immune system.

Product

BSD-2000

BSD-2000 Deep Regional Hyperthermia

BSD - 500

BSD-500 Superficial Hyperthermia

BSD-2000 3D

BSD-2000 3D TĂNG THÂN NHIỆT VÙNG SÂU

Products - BSD-500, BSD-2000/3D/MR

PYREXAR Hyperthermia (HT)systems deliver therapeutic heating via non invasive radio frequency (RF) energy in the 75-140 MHz range (BSD-500 delivers at a fixed 915 MHz) During PYREXAR HT treatment, the